412 related articles for article (PubMed ID: 30547858)
1. Nonconventional Therapeutics against
Grunenwald CM; Bennett MR; Skaar EP
Microbiol Spectr; 2018 Nov; 6(6):. PubMed ID: 30547858
[No Abstract] [Full Text] [Related]
2. Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.
Chung PY; Toh YS
Pathog Dis; 2014 Apr; 70(3):231-9. PubMed ID: 24453168
[TBL] [Abstract][Full Text] [Related]
3. Considerations and caveats in anti-virulence drug development.
Maura D; Ballok AE; Rahme LG
Curr Opin Microbiol; 2016 Oct; 33():41-46. PubMed ID: 27318551
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and virulence of
Cheung GYC; Bae JS; Otto M
Virulence; 2021 Dec; 12(1):547-569. PubMed ID: 33522395
[No Abstract] [Full Text] [Related]
5. Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review.
Gopikrishnan M; Haryini S; C GPD
J Basic Microbiol; 2024 May; 64(5):e2300579. PubMed ID: 38308076
[TBL] [Abstract][Full Text] [Related]
6. New Strategies Targeting Virulence Factors of Staphylococcus aureus and Pseudomonas aeruginosa.
François B; Luyt CE; Stover CK; Brubaker JO; Chastre J; Jafri HS
Semin Respir Crit Care Med; 2017 Jun; 38(3):346-358. PubMed ID: 28578557
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.
Fleitas Martínez O; Cardoso MH; Ribeiro SM; Franco OL
Front Cell Infect Microbiol; 2019; 9():74. PubMed ID: 31001485
[TBL] [Abstract][Full Text] [Related]
8. Phage endolysins as new therapeutic options for multidrug resistant
Belete MA; Tadesse S; Tilahun M; Alemayehu E; Saravanan M
Front Cell Infect Microbiol; 2024; 14():1397935. PubMed ID: 38953006
[No Abstract] [Full Text] [Related]
9. Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance.
Bhardwaj AK; Vinothkumar K; Rajpara N
Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):68-83. PubMed ID: 23394143
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections.
Magana M; Ioannidis A; Magiorkinis E; Ursu O; Bologa CG; Chatzipanagiotou S; Hamblin MR; Tegos GP
Curr Pharm Des; 2015; 21(16):2058-72. PubMed ID: 25760340
[TBL] [Abstract][Full Text] [Related]
11. Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.
Kane TL; Carothers KE; Lee SW
Curr Drug Targets; 2018; 19(2):111-127. PubMed ID: 27894236
[TBL] [Abstract][Full Text] [Related]
12. The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release.
Brackman G; Breyne K; De Rycke R; Vermote A; Van Nieuwerburgh F; Meyer E; Van Calenbergh S; Coenye T
Sci Rep; 2016 Feb; 6():20321. PubMed ID: 26828772
[TBL] [Abstract][Full Text] [Related]
13. Anti-Pathogenic Efficacy and Molecular Targets of a Polyherbal Wound- Care Formulation (Herboheal) Against Staphylococcus aureus.
Patel P; Joshi C; Kothari V
Infect Disord Drug Targets; 2019; 19(2):193-206. PubMed ID: 30345928
[TBL] [Abstract][Full Text] [Related]
14. Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections.
Khan BA; Yeh AJ; Cheung GY; Otto M
Expert Opin Investig Drugs; 2015 May; 24(5):689-704. PubMed ID: 25704585
[TBL] [Abstract][Full Text] [Related]
15. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus.
Assis LM; Nedeljković M; Dessen A
Drug Resist Updat; 2017 Mar; 31():1-14. PubMed ID: 28867240
[TBL] [Abstract][Full Text] [Related]
16. Innovative approaches to treat
Richter K; Van den Driessche F; Coenye T
Essays Biochem; 2017 Feb; 61(1):61-70. PubMed ID: 28258230
[TBL] [Abstract][Full Text] [Related]
17. Exploring the potential of isorhapontigenin: attenuating
Yuan L; Xi H; Luo Z; Liu M-f; Chen Q; Zhu Q; Zhao R; Sheng Y-y
mSphere; 2024 Jun; 9(6):e0031724. PubMed ID: 38837389
[TBL] [Abstract][Full Text] [Related]
18. VraR Binding to the Promoter Region of
Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
[TBL] [Abstract][Full Text] [Related]
19. Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus.
Dawgul M; Baranska-Rybak W; Kamysz E; Karafova A; Nowicki R; Kamysz W
Future Med Chem; 2012 Aug; 4(12):1541-51. PubMed ID: 22917244
[TBL] [Abstract][Full Text] [Related]
20. Comparative Assessment of Bacteriophage and Antibiotic Activity against Multidrug-Resistant
Kaźmierczak N; Grygorcewicz B; Roszak M; Bochentyn B; Piechowicz L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
